Evaluating topical minoxidil for treating acne vulgaris

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the toxicity and efficacy of topical minoxidil in patients with acne vulgaris. Participants aged 20 to 50 with mild to moderate acne will undergo baseline blood and urine tests, and their acne lesions will be monitored over a 14-day period. The primary objective is to evaluate the safety of minoxidil, while secondary objectives include measuring the response rate and time to resolution of acne lesions. Daily photographic documentation will be used to track treatment efficacy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Gender: both
2. Age limit: 20\~50 year/old
3. Acne vulgaris: mild to moderate degree (Investigator's Global Assessment Scale:2\~3)

Exclusion Criteria:

1. pregnant or breast feeding woman
2. allergic to minoxidil or any ingredient of minoxidil solution including alcohol and propylene glycol
3. deny to discontinue topical therapy of acne more than 7 days before starting treatment
4. deny to discontinue systemic therapy of acne more than 28 days before starting treatment
5. alopecia under or ever using minoxidil, known androgen-AR pathway blocker
6. using shampoo containing minoxidil component in 28 days before starting treatment
7. irregular menstruation of known case of polycystic ovarian syndrome
8. Have had a facial procedure 2 weeks before the study start
9. using any oral contraceptives that have a specific anti-androgenic action 12 weeks before the study start

Where it's running

• Linkou Chang Gung Memorial Hospital
  Taoyuan, Taiwan Recruiting

Study contacts

• Principal investigator: Cheng-Lung Hsu, Profesor — Chang Gung Memorial Hospital
• Study coordinator: Cheng-Lung Hsu, Profesor
• Email: hsu2221@cgmh.org.tw
• Phone: (886)33281200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nadifloxacin Plus Tretinoin vs Clindamycin Plus Tretinoin for Mild-to-Moderate Acne

  This study tests whether nadifloxacin with tretinoin cream works better than clindamycin with tretinoin cream for adults with mild-to-moderate acne.

  Recruiting Phase 4 Nishtar Medical University · Multan, Punjab Province · NCT07915648

• Topical clascoterone vs. adapalene for mild-to-moderate acne in teens and young adults

  This trial tests whether clascoterone 1% cream works as well as adapalene 0.1% cream for treating mild-to-moderate acne in people aged 12–55.

  Recruiting Pak Emirates Military Hospital · Rawalpindi, Punjab Province · NCT07883538

• Denifanstat vs placebo for moderate to severe acne in teens and adults

  This study tests whether denifanstat works safely to improve acne in people 12 and older, compared with a matching placebo.

  Recruiting at 28 sites Phase 3 Sagimet Biosciences Inc. · Bryant, Arkansas and 27 other locations · NCT07863193

• Facial skin microbiome changes during isotretinoin in moderate-to-severe acne

  This study tests how the facial skin microbiome changes in people with moderate-to-severe acne who are treated with isotretinoin, and compares them with healthy individuals.

  Recruiting Can Tho University of Medicine and Pharmacy · Can Tho · NCT07834138

• Prevalence of PMOS in women with acne at Sohag University Hospital

  This study tests how common polyendocrine metabolic ovarian syndrome (PMOS) is among women with acne who are seen at Sohag University Hospital.

  Recruiting Sohag University · Sohag · NCT07822360

• Hormonal profiles and isotretinoin response in adult women with acne

  This study tests whether baseline hormones (DHEAS, FSH, and LH) help predict how adult women with acne will respond to systemic isotretinoin.

  Recruiting Biruni University · Küçükçekmece, Istanbul · NCT07818525

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.